The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

ZEISS Metrology Shop provides planning security

ZEISS Metrology Shop brings it all together.

Pfizer slutar sälja uppmärksammad genterapi

Pfizer kommer att avbryta utvecklingen och försäljningen av sin uppmärksammade och extremt dyra genterapi mot blödarsjuka, Beqvez. Orsaken uppges vara bristande efterfrågan.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Webinar: Medtech quality and regulatory compliance

This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...

Årets mest lästa krönikor och opinionsartiklar

Branschspaningar och reflektioner är och har alltid varit en viktig del av Life Science Swedens redaktionella innehåll. När 2021 nu snart är till ända har vi sa...

Extensive agreements signed at Scilifelab

Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.

BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”

For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leavi...

ZEISS presents the "Quality Innovation Summit"

A global event on the future of quality assurance.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Life Science-podden: The perfect moment for an IPO

When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Medical Applications

Video about metrology solutions for medical components

USA lämnar Världshälsoorganisationen

USA:s nyinstallerade president Donald Trump har lagt en presidentorder på att USA ska lämna Världshälsoorganisationen, WHO.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Lösningar för precisionsreglering av gas och luft

OEM Automatic tillhandahåller ett omfattande sortiment av tryckregulatorer för precisionsreglering genom samarbeten med välrenommerade tillverkare som Tescom oc...

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Norway finds its path in life science

The life science sector in Norway is on the rise.

TCO easy comparison of electric and pneumatic solutions

Find the right technology for your application and compare CO₂ emission and TCO The shown results are not based on a sizing calculation, parameters like service...

Krönika: Collaboration across borders

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...